By Paul Mooney

In January 2009, two people died and nine were hospitalized in Xinjiang, China’s far northwest province, after they took a counterfeit diabetes drug that contained six times the normal dose of the medicine’s key ingredient, according to the state-run Xinhua news agency. (Click here to continue reading)

See also: In search of little blue pills

Image by Paul Mooney